Loading stock data…
$19.26+0.02 (+0.10%)
Stevanato Group S.p.A.
Stevanato Group S.p.A. in the Healthcare sector is trading at $19.26 with a market capitalization of $5.5B. Wall Street consensus targets $24.47 (13 analysts), implying a +27.0% move over the next 12 months. The stock is currently 31% below its 52-week high of $27.99, remaining 6.1% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 18 is oversold, raising the odds of a near-term bounce. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $302.00M↑ | $273.60M↓ | $346.48M↑ | $303.17M↑ | $280.04M |
| Gross Profit | $86.81M↑ | $75.20M↓ | $106.90M↑ | $88.50M↑ | $78.59M |
| Operating Income | $51.28M↑ | $38.80M↓ | $70.08M↑ | $52.72M↑ | $41.37M |
| Net Income | $22.96M↓ | $28.00M↓ | $47.55M↑ | $36.06M↑ | $29.70M |
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. ...